Read More Pharma Industry News Celltrion USA launches ZYMFENTRA for ulcerative colitis and Crohn’s disease In a significant advancement for patients with digestive disorders, Celltrion USA has announced the availability of ZYMFENTRA (infliximab-dyyb),… byPallavi MadhirajuMarch 18, 2024